<HashMap><database>biostudies-arrayexpress</database><scores/><additional><submitter/><organism>Homo sapiens</organism><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/E-MTAB-15004</full_dataset_link><description>Characterize the transcriptomes of CLL with and without t(14;19)</description><repository>biostudies-arrayexpress</repository><sample_protocol>Nucleic Acid Extraction - Total RNA was extracted with the RNeasy Mini Kit (Qiagen, Hilden, Germany) and treated with DNase (Qiagen), according to the manufacturer’s protocol</sample_protocol><sample_protocol>Sample Collection - 10^6 leukemic B cells from CLL patients. B cells were purified by negative selection using RosetteSep™ B cell enrichment Cocktail (StemCell Technologies, Vancouver, Canada)</sample_protocol><sample_protocol>Library Construction - Illumina Stranded mRNA Prep kit but replacing the messenger RNA capture phase with ribosomal RNA depletion performed with the Qiagen Qiaseq Fastselect HMR kit.</sample_protocol><sample_protocol>Sequencing - 150bp paired-end reads on Illumina NovaSeq 6000 (Illumina, Inc., San Diego, California - USA)</sample_protocol><figure_sub>MINSEQE Score</figure_sub><figure_sub>Assays and Data</figure_sub><figure_sub>Processed Data</figure_sub><figure_sub>organisation</figure_sub><figure_sub>MAGE-TAB Files</figure_sub><data_protocol>Data Transformation - Fastq data were processed with the CirComPara2 software pipeline; raw counts for genes were computed with the tximport-DESeq2 procedure from the StringTie2 output</data_protocol><omics_type>Metabolomics</omics_type><omics_type>Unknown</omics_type><omics_type>Transcriptomics</omics_type><omics_type>Genomics</omics_type><omics_type>Proteomics</omics_type><instrument_platform>Illumina NovaSeq 6000</instrument_platform><study_type>RNA-seq of total RNA</study_type><species>Homo sapiens</species><pubmed_title>Circular RNA signature of aggressive CLL with t(14;19)(q32;q13). An ERIC study.</pubmed_title><pubmed_title>Clinical and transcriptomic characterization of patients with chronic lymphocytic leukemia harboring t(14;19): an ERIC study.</pubmed_title><additional_accession>ERP171265</additional_accession><pubmed_authors>Visentin A, Gaffo E, Fürstenau M, Rogers KA, Panagiotis B, Cui C, Miller C, Haferlach C, Plevova K, Oscier D, Davis Z, Nguyen-Khac F, Roncaglia E, Rigolin GM, Athanasiadou A, Baran-Marszak F, Valiente A, Terol MJ, Abrisqueta P, Espinet B, Puiggros A, Martines A, Bonaldi L, Mauro FR, Scarfò L, Chatzikonstantinou T, Tausch E, Kreuzer KA, Kater A, Bosch F, Doubek M, Panagiotidis P, Kalashnikova O, Frezzato F, Calabretto G, Ruocco V, Orsi S, Cellini A, Angotzi F, Serafin A, Yi S, Eichhorst B, Woyach JA, Cuneo A, Ghia P, Stamatopoulos K, Trentin L, Bortoluzzi S.</pubmed_authors><pubmed_authors>Enrico Gaffo</pubmed_authors><pubmed_authors>Andrea Visentin</pubmed_authors><pubmed_authors>Roncaglia E, Gaffo E, Calabretto G, Fürstenau M, Rogers KA, Baliakas P, Cui C, Miller C, Haferlach C, Plevova K, Oscier D, Davis Z, Nguyen-Khac F, Rigolin GM, Athanasiadou A, Baran-Marszak F, Valiente A, Terol MJ, Abrisqueta P, Espinet B, Puiggros A, Martines A, Bonaldi L, Mauro FR, Scarfò L, Chatzikonstantinou T, Tausch E, Kreuzer KA, Kater A, Bosch F, Doubek M, Panagiotidis P, Kalashnikova O, Frezzato F, Ruocco V, Orsi S, Salek K, Merlo R, Caregari A, Glogovitis I, Cellini A, Angotzi F, Serafin A, Yi S, Eichhorst B, Woyach JA, Cuneo A, Ghia P, Stamatopoulos K, Trentin L, Visentin A, Bortoluzzi S.</pubmed_authors></additional><is_claimable>false</is_claimable><name>RNA-seq of Chronic Lymphocytic Leukemia patients with and without t(14;19) samples, and normal mature B cells</name><description>Characterize the transcriptomes of CLL with and without t(14;19)</description><dates><release>2026-07-14T00:00:00Z</release><modification>2026-07-14T13:16:33.131Z</modification><creation>2025-04-04T09:45:28.29Z</creation></dates><accession>E-MTAB-15004</accession><cross_references><pubmed>publ-0-eenf-removable</pubmed><pubmed>publ-1-h7rg-removable</pubmed><ENA>ERP171265</ENA><EFO>EFO_0002944</EFO><EFO>EFO_0004170</EFO><EFO>EFO_0009653</EFO><EFO>EFO_0005518</EFO><EFO>EFO_0003816</EFO><EFO>EFO_0004184</EFO><doi>10.1186/s13045-025-01725-y</doi><doi>10.1038/s41375-025-02755-8</doi></cross_references></HashMap>